Art

J-GLOBAL ID：201702247653187970   Reference number：17A1956486

A single institutional retrospective evaluation for younger patients with primary central nervous lymphomas on a modified R-MPV regimen followed by radiotherapy and high dose cytarabine

原発性中枢神経リンパ腫の若年患者を対象とした改訂版R-MPVレジメンとそれに続く放射線療法および高用量シタラビン投与に関する単一施設後ろ向き評価

Author (13)： Hattori Keiichiro (Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba) ,  Sakata-Yanagimoto Mamiko (Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba) ,  Okoshi Yasushi (Ibaraki Clinical Education and Training Center, University of Tsukuba Hospital; Department of Hematology, Ibaraki Prefectural Central Hospital) ,  Kato Takayasu (Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba) ,  Kurita Naoki (Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba) ,  Yokoyama Yasuhisa (Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba) ,  Obara Naoshi (Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba) ,  Takano Shingo (Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba) ,  Ishikawa Eiichi (Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba) ,  Yamamoto Tetsuya (Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba) ,  Matsumura Akira (Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba) ,  Hasegawa Yuichi (Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba) ,  Chiba Shigeru (Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba)
Material： Journal of Clinical and Experimental Hematopathology (Web)  (J Clin Exp Hematop (Web))
Volume： 57  Issue： 2  Page： 41-46(J-STAGE)  Publication year： 2017 
JST Material Number： U0778A  ISSN： 1880-9952  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： *Primary central nervous system lymphoma ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1956486&from=J-GLOBAL&jstjournalNo=U0778A") }}

Author keywords (3)： R-MPV induction therapy followed by consolidation rdWBRT and HD-AC ,  primary central nervous system lymphoma ,  CR after completion of treatment

JST classification (2)： Blood cell tumors(=neoplasms)  (GK04000M) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Substance index (1)： Cytarabine

Reference (31)：

• 1 Kluin P, Deckert M, Ferry J, Swerdlow SH, Campo E, et al. : WHO classification of tumours of haematopoietic and lymphoid tissues. 4^th ed, Lyon, IARC, pp. 240-241, 2008
• 2 Nelson DF, Martz KL, Bonner H, Nelson JS, Newall J, et al. : Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 23(1): 9-17, 1992
• 3 Prica A, Chan K, Cheung MC : Combined modality therapy versus chemotherapy alone as an induction regimen for primary central nervous system lymphoma: a decision analysis. Br J Haematol 158(5): 600-607, 2012
• 4 Morris PG, Correa DD, Yahalom J, Raizer JJ, Schiff D, et al. : Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. J Clin Oncol 31(31): 3971-3979, 2013
• 5 Holdhoff M, Ambady P, Abdelaziz A, Sarai G, Bonekamp D, et al. : High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma. Neurology 83(3): 235-239, 2014

Terms in the title (11)： 原発性中枢神経リンパ腫 ,  若年患者 ,  改訂 ,  R-MPV ,  レジメン ,  放射線療法 ,  高用量 ,  シタラビン ,  投与 ,  施設 ,  評価